Pre-infusion single-dose mesenchymal stem cells promote platelet engraftment and decrease severe acute graft versus host disease without relapse in haploidentical peripheral blood stem cell transplantation

BACKGROUND: Mesenchymal stem cells (MSCs) may be used to treat steroid-refractory graft versus host disease (GVHD). However, the effects of MSCs in haploidentical peripheral blood stem cell transplantation (haplo-PBSCT) have not been confirmed in randomized studies. METHODS: We conducted a randomize...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiaoning, Zhang, Mei, He, Pengcheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Prospective Clinical Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7221479/
https://www.ncbi.nlm.nih.gov/pubmed/32363972
http://dx.doi.org/10.1177/0300060520920438

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7221479/
https://www.ncbi.nlm.nih.gov/pubmed/32363972
http://dx.doi.org/10.1177/0300060520920438

Ejemplares similares